The Circadian System in Alzheimer’s Disease: Disturbances, Mechanisms, and Opportunities
暂无分享,去创建一个
Bernhard T. Baune | Andrew N. Coogan | Peter Kropp | B. Baune | J. Thome | B. Schutová | A. Coogan | P. Kropp | Susanne Husung | K. Furczyk | F. Hässler | Johannes Thome | Barbora Schutová | Susanne Husung | Karolina Furczyk | Frank Häßler
[1] A. Coogan,et al. DIURNAL, AGE, AND IMMUNE REGULATION OF INTERLEUKIN-1β AND INTERLEUKIN-1 TYPE 1 RECEPTOR IN THE MOUSE SUPRACHIASMATIC NUCLEUS , 2010, Chronobiology international.
[2] N. Rawlings,et al. Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro , 2001, Neuroscience.
[3] S. Ancoli-Israel,et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women , 2011, Alzheimer's & Dementia.
[4] S. Nam,et al. Inflammation and Alzheimer’s disease , 2010, Archives of pharmacal research.
[5] R. Kondratov,et al. The circadian clock and pathology of the ageing brain , 2012, Nature Reviews Neuroscience.
[6] A. Lewy. Melatonin and human chronobiology. , 2007, Cold Spring Harbor symposia on quantitative biology.
[7] W. Revelle,et al. Circadian phase-shifting effects of nocturnal exercise in older compared with young adults. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[8] S. Ancoli-Israel,et al. CIRCADIAN RHYTHMS OF AGITATION IN INSTITUTIONALIZED PATIENTS WITH ALZHEIMER'S DISEASE , 2000, Chronobiology international.
[9] J. T. Smith,et al. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease , 2012, Experimental Neurology.
[10] D. F. Swaab,et al. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia , 1985, Brain Research.
[11] J. Thome,et al. Haloperidol alters circadian clock gene product expression in the mouse brain , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[12] B. Baune,et al. Neuroimmunomodulation in unipolar depression: a focus on chronobiology and chronotherapeutics , 2012, Journal of Neural Transmission.
[13] R. Nelson,et al. Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice , 2011, Proceedings of the National Academy of Sciences.
[14] P. Scheltens,et al. Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial , 2010, Trials.
[15] J R Hodges,et al. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. , 2004, Brain : a journal of neurology.
[16] Thomas Reilly,et al. Strong association of the rest-activity rhythm with well-being in demented elderly women. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[17] S. Klaffke,et al. Sundowning and circadian rhythm disorders in dementia. , 2006, Acta neurologica Belgica.
[18] C. Wyse,et al. Impact of aging on diurnal expression patterns of CLOCK and BMAL1 in the mouse brain , 2010, Brain Research.
[19] C. McClung,et al. Circadian rhythms and mood regulation: Insights from pre-clinical models , 2011, European Neuropsychopharmacology.
[20] M. Mirmiran,et al. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients , 1997, Biological Psychiatry.
[21] C. Marotta,et al. Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. Connor,et al. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[23] P. Zandi,et al. Apolipoprotein E Genotype and Mortality: Findings from the Cache County Study , 2005, Journal of the American Geriatrics Society.
[24] Andrew N. Coogan,et al. Chronotherapeutics and psychiatry: Setting the clock to relieve the symptoms , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[25] R. Foster,et al. Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease , 2010, Nature Reviews Neuroscience.
[26] A. McKee,et al. Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia. , 2008, Brain : a journal of neurology.
[27] M. Okawa,et al. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia , 1994, Acta psychiatrica Scandinavica.
[28] M. Hofman,et al. Living by the clock: The circadian pacemaker in older people , 2006, Ageing Research Reviews.
[29] B. Rusak,et al. Localization of cholinergic neurons in the forebrain and brainstem that project to the suprachiasmatic nucleus of the hypothalamus in rat , 1993, The Journal of comparative neurology.
[30] Christianna S. Williams,et al. The Effect of Ambient Bright Light Therapy on Depressive Symptoms in Persons with Dementia , 2007, Journal of the American Geriatrics Society.
[31] Gernot Riedel,et al. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse. , 2010, Journal of Alzheimer's disease : JAD.
[32] W. Kamphorst,et al. Decreased Vasopressin Gene Expression in the Biological Clock of Alzheimer Disease Patients With and Without Depression , 2000, Journal of neuropathology and experimental neurology.
[33] Diane B. Boivin,et al. Circadian Clock Gene Expression in Brain Regions of Alzheimer ’s Disease Patients and Control Subjects , 2011, Journal of biological rhythms.
[34] Darren J Moore,et al. Genetic mouse models of neurodegenerative diseases. , 2011, Progress in molecular biology and translational science.
[35] J. Yesavage,et al. The Relations among Caregiver Stress, “Sundowning” Symptoms, and Cognitive Decline in Alzheimer's Disease , 1992, Journal of the American Geriatrics Society.
[36] J. Thome,et al. Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels , 2012, Molecular Psychiatry.
[37] J. Yesavage,et al. Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: A role for cholinergic transmission , 2005, Neuroscience.
[38] E. Stopa,et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. , 1999, Journal of neuropathology and experimental neurology.
[39] D. Cardinali,et al. Effect of Melatonin on Changes in Locomotor Activity Rhythm of Syrian Hamsters Injected with Beta Amyloid Peptide 25–35 in the Suprachiasmatic Nuclei , 2002, Cellular and Molecular Neurobiology.
[40] M. Korte,et al. The Secreted β-Amyloid Precursor Protein Ectodomain APPsα Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice , 2007, The Journal of Neuroscience.
[41] R. Dyck,et al. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes , 2010, Brain Research.
[42] LuAnn Etcher,et al. Nonlinear indices of circadian changes in individuals with dementia and aggression , 2012, Psychiatry Research.
[43] J. Waterhouse. Circadian rhythms and cognition. , 2010, Progress in brain research.
[44] Anna Wirz-Justice,et al. Dawn–dusk simulation light therapy of disturbed circadian rest–activity cycles in demented elderly , 2003, Experimental Gerontology.
[45] Philip Scheltens,et al. Circadian rest—activity rhythm disturbances in alzheimer's disease , 1996, Biological Psychiatry.
[46] R. D'Hooge,et al. Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition , 2003, The European journal of neuroscience.
[47] L. Thal,et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. , 2003, Sleep.
[48] M. Figueiro,et al. Field measurements of light exposures and circadian disruption in two populations of older adults. , 2012, Journal of Alzheimer's disease : JAD.
[49] Judy Mastick,et al. Effect of morning bright light treatment for rest–activity disruption in institutionalized patients with severe Alzheimer's disease , 2005, International Psychogeriatrics.
[50] S. Amir,et al. A Circadian Rhythm in the Expression of PERIOD2 Protein Reveals a Novel SCN-Controlled Oscillator in the Oval Nucleus of the Bed Nucleus of the Stria Terminalis , 2004, The Journal of Neuroscience.
[51] A. Wirz-Justice,et al. Haloperidol Disrupts, Clozapine Reinstates the Circadian Rest–Activity Cycle in a Patient With Early-Onset Alzheimer Disease , 2000, Alzheimer disease and associated disorders.
[52] Yaakov Stern,et al. Disruptive behavior as a predictor in Alzheimer disease. , 2007, Archives of neurology.
[53] D. Fish,et al. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease , 2004, Neurobiology of Aging.
[54] P. Scheltens,et al. Increased skin temperature in Alzheimer’s disease is associated with sleepiness , 2012, Journal of Neural Transmission.
[55] S. Reppert,et al. Coordination of circadian timing in mammals , 2002, Nature.
[56] R. Galani,et al. Modulation of photic resetting in rats by lesions of projections to the suprachiasmatic nuclei expressing p75 neurotrophin receptor , 2004, European Journal of Neuroscience.
[57] C. Colwell,et al. Phase-shifting mechanisms in the mammalian circadian system: new light on the carbachol paradox , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[58] Andrew N. Coogan,et al. Neuroimmunology of the circadian clock , 2008, Brain Research.
[59] S. Endo,et al. Effects of bright light on cognitive and sleep–wake (circadian) rhythm disturbances in Alzheimer‐type dementia , 2000, Psychiatry and clinical neurosciences.
[60] J. Viña,et al. Circadian System Functionality, Hippocampal Oxidative Stress, and Spatial Memory in the APPswe/PS1dE9 Transgenic Model of Alzheimer Disease: Effects of Melatonin or Ramelteon , 2012, Chronobiology international.
[61] D F Swaab,et al. Suprachiasmatic nucleus of the human brain: An immunocytochemical and morphometric analysis , 1996, The Anatomical record.
[62] C. Schmidt,et al. A time to think: Circadian rhythms in human cognition , 2007, Cognitive neuropsychology.
[63] R. Silver,et al. Minireview: The neuroendocrinology of the suprachiasmatic nucleus as a conductor of body time in mammals. , 2007, Endocrinology.
[64] A. Satlin,et al. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease. , 1992, The American journal of psychiatry.
[65] J. Luxenberg,et al. Melatonin and Bright‐Light Treatment for Rest–Activity Disruption in Institutionalized Patients with Alzheimer's Disease , 2008, Journal of the American Geriatrics Society.
[66] M. Gorman,et al. LIFESPAN DAILY LOCOMOTOR ACTIVITY RHYTHMS IN A MOUSE MODEL OF AMYLOID-INDUCED NEUROPATHOLOGY , 2010, Chronobiology international.
[67] D. Cutler,et al. Aberrant Gating of Photic Input to the Suprachiasmatic Circadian Pacemaker of Mice Lacking the VPAC2 Receptor , 2004, Journal of Neuroscience.
[68] Dick F Swaab,et al. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. , 2008, JAMA.
[69] S. Engelborghs,et al. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances , 2004, The European journal of neuroscience.
[70] Steven A Brown,et al. Peripheral Circadian Oscillators , 2008, Annals of the New York Academy of Sciences.
[71] Sonia Ancoli-Israel,et al. Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer's Disease Patients , 2003, Behavioral sleep medicine.
[72] M. Binns,et al. Meal delivery practices do not meet needs of Alzheimer patients with increased cognitive and behavioral difficulties in a long-term care facility. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[73] F. Scheer,et al. The suprachiasmatic nucleus functions beyond circadian rhythm generation , 2007, Neuroscience.
[74] S. Allan,et al. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer’s disease (3xTgAD) mice , 2012, Disease Models & Mechanisms.
[75] Kun Hu,et al. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: Involvement of the circadian pacemaker , 2009, Proceedings of the National Academy of Sciences.
[76] D. Swaab,et al. VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease , 1995, Neurobiology of Aging.
[77] D. Aarsland,et al. Improvement in behavioral symptoms and advance of activity acrophase after short‐term bright light treatment in severe dementia , 2004, Psychiatry and clinical neurosciences.
[78] M. Mirmiran,et al. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease , 1990, Biological Psychiatry.
[79] G. Frisoni,et al. Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. , 1995, Dementia.
[80] S. Endo,et al. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
[81] B. C. Manning,et al. Sundowning and circadian rhythms in Alzheimer's disease. , 2001, The American journal of psychiatry.
[82] R. J. McDonald,et al. Cholinergic depletion of the medial septum followed by phase shifting does not impair memory or rest–activity rhythms measured under standard light/dark conditions in rats , 2009, Brain Research Bulletin.
[83] D. Swaab,et al. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer’s disease , 2007, Experimental Gerontology.
[84] J. Luxenberg,et al. Effect of timed bright light treatment for rest‐activity disruption in institutionalized patients with Alzheimer's disease , 2005, International journal of geriatric psychiatry.
[85] U. Schibler,et al. The mammalian circadian timing system: organization and coordination of central and peripheral clocks. , 2010, Annual review of physiology.
[86] J. Gerstner,et al. Circadian rhythms and memory formation , 2010, Nature Reviews Neuroscience.
[87] E. Zee,et al. The cholinergic system, circadian rhythmicity, and time memory , 2011, Behavioural Brain Research.
[88] Chadi Touma,et al. Activity changes and marked stereotypic behavior precede A β pathology in TgCRND8 Alzheimer mice , 2006, Neurobiology of Aging.
[89] Chaur-Jong Hu,et al. Expression of inducible nitric oxide synthase (iNOS) and period 1 (PER1) clock gene products in different sleep stages of patients with cognitive impairment , 2010, Journal of Clinical Neuroscience.
[90] M. Korte,et al. The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[91] Anna Wirz-Justice,et al. Biological rhythm disturbances in mood disorders , 2006, International clinical psychopharmacology.
[92] A. McKee,et al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. , 2001, Archives of general psychiatry.